{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:33:22Z","timestamp":1758342802087,"version":"3.44.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cardiogenic shock (CS) is a complex syndrome characterized by inadequate tissue perfusion due to reduced cardiac output resulting from a wide array of underlying causes. It is generally an acute and devastating condition with short-term mortality ranging from 30% to 40% and 1-year mortality around 50%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 31-year-old previously healthy male presented with progressive dyspnoea, fatigue, and signs of low perfusion, ultimately developing CS requiring ICU admission. Transthoracic echocardiography revealed severe left ventricular dysfunction (left ventricular ejection fraction 18%) with diffuse hypokinesia and moderate functional mitral regurgitation (Type IIIb). Despite high-dose inotropic support (dobutamine, milrinone) and vasopressors, the patient remained in refractory shock. A therapeutic trial with sodium nitroprusside led to transient haemodynamic improvement, followed by a secondary deterioration. Due to unavailability of immediate mechanical circulatory support (MCS), levosimendan was initiated at 0.1\u2005\u03bcg\/kg\/min (without loading dose), resulting in rapid and sustained clinical improvement and weaning from vasoactive agents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Given the heterogeneous nature of CS and the various physiological derangements, several vasoactive medications may be attempted to try to stabilize or reverse the haemodynamic picture with or without the installation of MCS. These devices have evolved as novel treatment strategies to restore systemic perfusion to allow cardiac recovery in the short-term. But, this case demonstrates the potential of combining vasodilator and inotropic therapies\u2014specifically dobutamine and milrinone with sodium nitroprusside and levosimendan\u2014as a bridge strategy in severe CS when MCS is not feasible.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf430","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:13:14Z","timestamp":1756483994000},"source":"Crossref","is-referenced-by-count":0,"title":["Staggered use of sodium nitroprusside and levosimendan in a patient with refractory cardiogenic shock: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-0327","authenticated-orcid":false,"given":"Andre Rodrigues","family":"Duraes","sequence":"first","affiliation":[{"name":"UTI3\/Hospital Tereza de Lisieux\u2014Hapvida NotreDame , Av. Ant\u00f4nio Carlos Magalh\u00e3es, 2408 - Itaigara, Salvador, BA 41825-000 ,","place":["Brazil"]},{"name":"Departamento de Cardiologia\/Hospital Universit\u00e1rio Prof Edgar Santos (HUPES)\/Universidade Federal da Bahia (UFBa) - R. Dr. Augusto Viana, s\/n\u2014Canela, Salvador, BA 40110-060 ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"de Souza Lima Bitar","sequence":"additional","affiliation":[{"name":"UTI3\/Hospital Tereza de Lisieux\u2014Hapvida NotreDame , Av. Ant\u00f4nio Carlos Magalh\u00e3es, 2408 - Itaigara, Salvador, BA 41825-000 ,","place":["Brazil"]},{"name":"Departamento de Cardiologia\/Hospital Universit\u00e1rio Prof Edgar Santos (HUPES)\/Universidade Federal da Bahia (UFBa) - R. Dr. Augusto Viana, s\/n\u2014Canela, Salvador, BA 40110-060 ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geonys Marlan","family":"Gon\u00e7alves Oliveira","sequence":"additional","affiliation":[{"name":"UTI3\/Hospital Tereza de Lisieux\u2014Hapvida NotreDame , Av. Ant\u00f4nio Carlos Magalh\u00e3es, 2408 - Itaigara, Salvador, BA 41825-000 ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Rosamar Vieira","family":"Franklin","sequence":"additional","affiliation":[{"name":"UTI3\/Hospital Tereza de Lisieux\u2014Hapvida NotreDame , Av. Ant\u00f4nio Carlos Magalh\u00e3es, 2408 - Itaigara, Salvador, BA 41825-000 ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus Batista Vieira Lima","family":"Junior","sequence":"additional","affiliation":[{"name":"UTI3\/Hospital Tereza de Lisieux\u2014Hapvida NotreDame , Av. Ant\u00f4nio Carlos Magalh\u00e3es, 2408 - Itaigara, Salvador, BA 41825-000 ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2025091917333430800_ytaf430-B1","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/cc11366","article-title":"Clinical validation of a new thermodilution system for the assessment of cardiac output and volumetric parameters","volume":"16","author":"Kiefer","year":"2012","journal-title":"Crit Care"},{"key":"2025091917333430800_ytaf430-B2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","author":"Nohria","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025091917333430800_ytaf430-B3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-075067572-7.50006-0","volume-title":"Cardiothoracic Critical Care","author":"Sniecinski","year":"2007"},{"key":"2025091917333430800_ytaf430-B4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025091917333430800_ytaf430-B5","doi-asserted-by":"crossref","first-page":"107395","DOI":"10.1016\/j.vph.2024.107395","article-title":"Sodium nitroprusside infusion in patients with advanced heart failure","volume":"156","author":"Ghio","year":"2024","journal-title":"Vascul Pharmacol"},{"key":"2025091917333430800_ytaf430-B6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0002-8703(97)70030-9","article-title":"Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function","volume":"134","author":"Capomolla","year":"1997","journal-title":"Am Heart J"},{"key":"2025091917333430800_ytaf430-B7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14740338.2024.2348570","article-title":"The cardiovascular safety of sodium nitroprusside in acute heart failure","volume":"23","author":"Bocchino","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"2025091917333430800_ytaf430-B8","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.15420\/ecr.2024.16","article-title":"levosimendan, a promising pharmacotherapy in cardiogenic shock: a comprehensive review","volume":"19","author":"Susilo","year":"2024","journal-title":"Eur Cardiol"},{"key":"2025091917333430800_ytaf430-B9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FJC.0000000000000859","article-title":"Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use","volume":"76","author":"Papp","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025091917333430800_ytaf430-B10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40256-024-00683-z","article-title":"Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning","volume":"25","author":"Zeitouni","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025091917333430800_ytaf430-B11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13613-025-01457-9","article-title":"Does levosimendan hasten veno-arterial ECMO weaning? A propensity score matching analysis","volume":"15","author":"Paulo","year":"2025","journal-title":"Ann Intensive Care"},{"key":"2025091917333430800_ytaf430-B12","doi-asserted-by":"crossref","first-page":"912321","DOI":"10.3389\/fcvm.2022.912321","article-title":"Early levosimendan administration improved weaning success rate in extracorporeal membrane oxygenation in patients with cardiogenic shock","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025091917333430800_ytaf430-B13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/0267659120918473","article-title":"Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis","volume":"35","author":"Burgos","year":"2020","journal-title":"Perfusion"},{"key":"2025091917333430800_ytaf430-B14","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025091917333430800_ytaf430-B15","first-page":"89","article-title":"Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series","volume":"10","author":"Lehmann","year":"2004","journal-title":"Med Sci Monit"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf430\/64162646\/ytaf430.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/9\/ytaf430\/64162646\/ytaf430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/9\/ytaf430\/64162646\/ytaf430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:33:38Z","timestamp":1758317618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf430\/8244193"}},"subtitle":[],"editor":[{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf430","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,29]]},"article-number":"ytaf430"}}